Söndag 27 April | 00:58:54 Europe / Stockholm

Kalender

Est. tid*
2025-08-29 20:40 Kvartalsrapport 2025-Q2
2025-05-30 N/A X-dag ordinarie utdelning OBSRV 0.00 NOK
2025-05-28 N/A Årsstämma
2025-03-18 - Bokslutskommuniké 2024
2025-01-14 - Split OBSRV 15:1
2025-01-07 - Extra Bolagsstämma 2025
2024-08-26 - Kvartalsrapport 2024-Q2
2024-05-27 - X-dag ordinarie utdelning OBSRV 0.00 NOK
2024-05-24 - Årsstämma
2024-03-13 - Bokslutskommuniké 2023
2023-11-22 - Extra Bolagsstämma 2023
2023-08-25 - Kvartalsrapport 2023-Q2
2023-05-30 - X-dag ordinarie utdelning OBSRV 0.00 NOK
2023-05-26 - Årsstämma
2023-02-17 - Bokslutskommuniké 2022
2022-11-03 - 15-10 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-06-03 - X-dag ordinarie utdelning OBSRV 0.00 NOK
2022-06-03 - Årsstämma
2022-03-29 - Bokslutskommuniké 2021
2022-02-04 - Extra Bolagsstämma 2022
2021-11-03 - Kvartalsrapport 2021-Q3
2021-08-20 - Kvartalsrapport 2021-Q2
2021-05-25 - X-dag ordinarie utdelning OBSRV 0.00 NOK
2021-05-21 - Årsstämma
2021-05-12 - Kvartalsrapport 2021-Q1
2021-02-23 - Bokslutskommuniké 2020
2020-11-03 - Kvartalsrapport 2020-Q3
2020-08-18 - Kvartalsrapport 2020-Q2
2020-07-01 - X-dag ordinarie utdelning OBSRV 0.00 NOK
2020-06-30 - Årsstämma
2020-06-16 - Extra Bolagsstämma 2020
2020-05-12 - Kvartalsrapport 2020-Q1
2020-02-25 - Bokslutskommuniké 2019

Beskrivning

LandNorge
ListaOAX Equities
SektorHälsovård
IndustriMedicinteknik
Observe Medical är ett norskt bolag verksamma inom medicinteknik. Bolaget bedriver utveckling av tekniska instrument som används inom intensivvården. Produkterna säljs under olika varumärken och är särskilt specialiserade för urinmätning. Störst verksamhet återfinns inom den nordiska samt europeiska marknaden. Bolaget kom till som en avknoppning från Navamedic och har sitt huvudkontor i Oslo, Norge.
2025-03-13 13:32:06
Oslo, 13 March, 2025 - Observe Medical ("the Company" or "Observe Medical") has
received repeat orders and now first significant orders from the Nordic region
where UnoMeter[T] Safeti[T] Plus historically has held a very dominating
position.

Historically, UnoMeter[T] Safeti[T] Plus has had a dominating market share in
this region consistently exceeding 70% across most markets. The annual sales to
the region has historically been at a level of approximately 15 mNOK, and the re
-introduction of UnoMeter[T] Safeti[T] Plus has been anticipated and now well
received.

Jørgen Mann, CEO of Observe Medical, commented: "The Nordic Region has
historically been dominated by UnoMeter[T] Safeti[T] Plus and the market share
has even reached 100% in some of the markets. We experience that customers have
been reaching out to us for some time now in anticipation for the re-launch of
UnoMeter[T] Safeti[T] Plus and we have seen that tender processes have even been
delayed to make sure UnoMeter[T] Safeti[T] Plus were ready and could be part of
the process. There are several tenders currently active in the region and we
expect to be able to continue the journey of taking back the position as the
preferred solution for urine output measurement"

For further information, please contact:

Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67558
E-mail: jorgen.mann@observemedical.com

Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12765
E-mail: johan.fagerli@observemedical.com

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.

The Company is headquartered in Oslo, Norway.

Further information is available atwww.observemedical.com.